The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein
Open accessAbstract
Tenascin-C (TN-C) is an extracellular matrix protein that is overexpressed during tissue remodeling processes, including tumor growth. To identify an aptamer for testing as a tumor-selective ligand, SELEX (systematic evolution of ligands by exponential enrichment) procedures were performed using both TN-C and TN-C-expressing U251 glioblastoma cells. The different selection techniques yielded TN-C aptamers that are related in sequence. In addition, a crossover procedure that switched from tumor cell to purified protein selections was effective in isolating two high-affinity TN-C aptamers. When targeting tumor cells in vitro, the observed propensity of naive oligonucleotide pools to evolve TN-C aptamers may be due to the abundance of this protein. In vivo, TN-C abundance may also be well suited for aptamer accumulation in the tumor milieu. A size-minimized and nuclease-stabilized aptamer, TTA1, binds to the fibrinogen-like domain of TN-C with an equilibrium dissociation constant (K(d)) of 5 x 10(-9) m. At 13 kDa, this aptamer is intermediate in size between peptides and single chain antibody fragments, both of which are superior to antibodies for tumor targeting because of their smaller size. TTA1 defines a new class of ligands that are intended for targeted delivery of radioisotopes or chemical agents to diseased tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
Mathews, D. H., Sabina, J., Zuker, M., & Turner, D. H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2700 · Cited by 3,795
Oligonucleotide inhibitors of human thrombin that bind distinct epitopes
Tasset, D. M., Kubik, M. F., & Steiner, W. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1275 · Cited by 837
DIVERSITY OF OLIGONUCLEOTIDE FUNCTIONS
Gold, L., Polisky, B., Uhlenbeck, O., & Yarus, M. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003555 · Cited by 805
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Tenascin: An Extracellular Matrix Protein Prominent in Specialized Embryonic Tissues and Tumors
Erickson, H. P., & Bourdon, M. A. (1989) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.05.110189.000443 · Cited by 605
Karlsson, R., & Fält, A. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(96)00195-0 · Cited by 568
Induction of tenascin in healing wounds
Mackie, E. J., Halfter, W., & Liverani, D. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2757 · Cited by 555
RNA Biochemistry and Biotechnology
(1999) · Springer eBooks · doi:10.1007/978-94-011-4485-8 · Cited by 419
Synthesis, deprotection, analysis and purification of RNA and ribosomes
Wincott, F., DiRenzo, A., Shaffer, C., Grimm, S., Tracz, D., Workman, C., Sweedler, D., Gonzalez, C., Scaringe, S., & Usman, N. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2677 · Cited by 398
Inhibitory DNA Ligands to Platelet-Derived Growth Factor B-Chain
Green, L. S., Jellinek, D., Jenison, R., Östman, A., Heldin, C.-H., & Janjic, N. (1996) · Biochemistry · doi:10.1021/bi961544+ · Cited by 390
[13] Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors
Morton, T. A., & Myszka, D. G. (1998) · Methods in Enzymology · doi:10.1016/s0076-6879(98)95044-3 · Cited by 308
Aptamers as therapeutic and diagnostic reagents: problems and prospects
Osborne, S. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80102-0 · Cited by 288
Green, L. S., Jellinek, D., Bell, C., Beebe, L. A., Feistner, B. D., Gill, S. C., Jucker, F. M., & Janjić, N. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90032-2 · Cited by 284
Tenascin is a stromal marker for epithelial malignancy in the mammary gland.
Mackie, E. J., Chiquet-Ehrismann, R., Pearson, C. A., Inaguma, Y., Taya, K., Kawarada, Y., & Sakakura, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4621 · Cited by 272
Irvine, D., Tuerk, C., & Gold, L. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90509-5 · Cited by 266
Koukoulis, G. K., Gould, V. E., Bhattacharyya, A., Gould, J. E., Howeedy, A. A., & Virtanen, I. (1991) · Human Pathology · doi:10.1016/0046-8177(91)90285-w · Cited by 222
Aukhil, I., Joshi, P., Yan, Y., & Erickson, H. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53809-6 · Cited by 221
Siri, A., Carnemolla, B., Saginati, M., Leprini, A., Casari, G., Baralle, F., & Zardi, L. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.3.525 · Cited by 198
Bigner, D. D., Brown, M. T., Friedman, A. H., Coleman, R. E., Akabani, G., Friedman, H. S., Thorstad, W. L., McLendon, R. E., Bigner, S. H., Zhao, X. G., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2202 · Cited by 192
Combinatorial selection of high affinity RNA ligands to live African trypanosomes
Homann, M., & Goringer, H. U. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.9.2006 · Cited by 190
Fitzwater, T., & Polisky, B. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)67019-0 · Cited by 172
Escort aptamers: a delivery service for diagnosis and therapy
Hicke, B. J., & Stephens, A. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11324 · Cited by 169
Self-citationBorsi, L., Carnemolla, B., Nicolò, G., Spina, B., Tanara, G., & Zardi, L. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520504 · Cited by 168
Tenascin-C Is Expressed in Macrophage-Rich Human Coronary Atherosclerotic Plaque
Wallner, K., Li, C., Shah, P. K., Fishbein, M. C., Forrester, J. S., Kaul, S., & Sharifi, B. G. (1999) · Circulation · doi:10.1161/01.cir.99.10.1284 · Cited by 160
On the properties and utility of a membrane filter assay in the study of isoleucyl-tRNA synthetase
Yarus, M., & Berg, P. R. (1970) · Analytical Biochemistry · doi:10.1016/0003-2697(70)90207-1 · Cited by 159
Tenascin expression in astrocytomas correlates with angiogenesis.
Zagzag, D., Friedlander, D. R., Miller, D. C., Dosik, J., Cangiarella, J. F., Kostianovsky, M., Cohen, H. W., Grumet, M., & GRECO, M. A. (1995) · PubMed · Cited by 156
Ishihara, A., Yoshida, T., Tamaki, H., & Sakakura, T. (1995) · PubMed · Cited by 150
Zagzag, D., Friedlander, D. R., Dosik, J., Chickramane, S., Chan, W., GRECO, M. A., Allen, J. C., Dorovini‐Zis, K., & Grumet, M. (1996) · PubMed · Cited by 135
Jahkola, T., Toivonen, T., Virtanen, I., von Smitten, K., Nordling, S., von Boguslawski, K., Haglund, C., Nevanlinna, H. A., & BLOMQVIST, C. P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.714 · Cited by 115
Aptamers as Tools in Molecular Biology and Immunology
Famulok, M., & Mayer, G. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60142-2_7 · Cited by 112
Yokoyama, K., Erickson, H., Ikeda, Y., & Takada, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000610200 · Cited by 90
Tenascin expression in human glioma cell lines and normal tissues
Ventimiglia, J. B., Wikstrand, C. J., Ostrowski, L. E., Bourdon, M. A., Lightner, V. A., & Bigner, D. D. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90029-k · Cited by 90
Oligonucleotide Inhibitors of P-Selectin-Dependent Neutrophil-Platelet Adhesion
JENISON, R. D., Jennings, S. D., WALKER, D. W., Bargatze, R. F., & Parma, D. H. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.265 · Cited by 88
Self-citationPietro Riva, G. F. (1999) · Acta Oncologica · doi:10.1080/028418699431438 · Cited by 87
The mathematics of SELEX against complex targets
Vant-Hull, B., Payano-Baez, A., Davis, R. H., & Gold, L. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1727 · Cited by 86
Watson, S. R., Chang, Y.-F., O'Connell, D., WEIGAND, L., Ringquist, S., & Parma, D. H. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.63 · Cited by 79
Self-citationExpression of Tenascin-C in intraductal carcinoma of human breast: relationship to invasion
Jahkola, T., Toivonen, T., Nordling, S., von Smitten, K., & Virtanen, I. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00215-9 · Cited by 69
Tenascin expression in human dermis is related to epidermal proliferation.
Schalkwijk, J., Steijlen, P. M., van Vlijmen-Willems, I. M., OOSTERLING, B., Mackie, E. J., & Verstraeten, A. A. (1991) · PubMed Central · Cited by 66
Dueck, M., Riedl, S., Hinz, U., Tandara, A. A., M�ller, P., Herfarth, C. H., & Faissner, A. (1999) · International Journal of Cancer · Cited by 57
Brock, S. C., Bonsall, J. M., & Luskin, M. B. (1998) · Methods · doi:10.1006/meth.1998.0684 · Cited by 54
Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma
Ibrahim, S. N., Lightner, V. A., Ventimiglia, J. B., Ibrahim, G. K., Walther, P. J., Bigner, D. D., & Humphrey, P. A. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90112-t · Cited by 53
Specific expression of tenascin in human colonic neoplasms
Sakai, T., Kawakatsu, H., Hirota, N., Yokoyama, T., Sakakura, T., & Saito, M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.194 · Cited by 49
Lightner, V. A., SLEMP, C. A., & Erickson, H. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17935.x · Cited by 34
Tenascin Expression and Angiogenesis in Breast Cancers
Tõkés, A., Hortoványi, E., Kulka, J., et al. (1999) · Pathology - Research and Practice · doi:10.1016/s0344-0338(99)80104-6 · Cited by 25
Xue, Li, L., Latijnhouwers, Smedts, Umbas, Aalders, Debruyne, de la Rosette, J. J. M. C. H., & Schalken (1998) · British Journal of Urology · doi:10.1046/j.1464-410x.1998.00659.x · Cited by 25
Estimation of SELEX pool size by measurement of DNA renaturation rates
Charlton, J., & Smith, D. (1999) · RNA · doi:10.1017/s1355838299991021 · Cited by 25
Tenascin-C Expression in Ultrastructurally Defined Angiogenic and Vasculogenic Lesions
Kostianovsky, M., GRECO, M. A., Cangiarella, J. F., & Zagzag, D. (1997) · Ultrastructural Pathology · doi:10.3109/01913129709016370 · Cited by 20
Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel
Riedl, S., Kadmon, M., Tandara, A. A., Hinz, U., Möller, P., Herfarth, C. H., & Faissner, A. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02236901 · Cited by 20
Cited by
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
SELEX—A (r)evolutionary method to generate high-affinity nucleic acid ligands
Stoltenburg, R., Reinemann, C., & Strehlitz, B. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.06.001 · Cited by 1,430
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Development of DNA aptamers using Cell-SELEX
Sefah, K., Shangguan, D., Xiong, X., O'Donoghue, M. B., & Tan, W. (2010) · Nature Protocols · doi:10.1038/nprot.2010.66 · Cited by 918
Metadata
- Authors
- Hicke, B. J., Marion, C., Chang, Y.-F., Gould, T., Lynott, C. K., Parma, D., Schmidt, P. G., & Warren, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 276
- Issue
- 52
- Pages
- 48644-48654
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2038167103
- Cited by
- 324
- References
- 49
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.